Drug News: May 2014A review of launches, new indications, Health Canada advisories and new dosage guidelines Press Review - May 30, 2014 New Brunswick Medical Society: Public health officers need more independence Xeljanz: first oral JAK inhibitor for rheumatoid arthritis Used for moderately to severely active disease in adults with an inadequate response to methotrexate. Updated Canadian statement on herpes zoster vaccine C. difficile: Waging a difficult battle Concerns and current issues in prevention and treatment of clostridium difficile infection. McGill nurses turn hope into action Changes to Canadian recommendations for pertussis vaccination Press Review - May 23, 2014 Vaccines: Why bother? Here’s why! First Previous 506 507 508 509 510 Next Last
